Clinical Trials Logo

Acute Hematogenous Osteomyelitis clinical trials

View clinical trials related to Acute Hematogenous Osteomyelitis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03846804 Completed - Osteomyelitis Clinical Trials

Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections

KDG-002
Start date: September 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the use of a blood test: Karius® plasma-based next-generation sequencing test (Karius Test), to see if we can detect and measure the infection causing agent in children with musculoskeletal infections (MSKI).

NCT ID: NCT01922011 Completed - Clinical trials for Acute Hematogenous Osteomyelitis

Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)

Start date: September 13, 2013
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determine whether daptomycin is effective and safe in the treatment of pediatric participants with AHO when compared to vancomycin (or equivalent) or nafcillin (or β-lactam equivalent). The primary hypothesis is that daptomycin is non-inferior compared with vancomycin (or equivalent) or nafcillin (or β-lactam equivalent) with respect to improvement in Pain, Inflammation, and Limb Function on or before study Day 5.